Zoom: https://rutgers.zoom.us/s/91084465841?pwd=jsaP5tt7bC6ZM6yFP5VugVBe7e2fDa.1
Meeting ID: 910 8446 5841, Password: 860102

Objectives
At the conclusion of this activity, participants should be better able to:
1. Assess the latest evidence-based diagnosis and care of patients with neurologic diseases
2. Evaluate the clinical efficacy and safety of therapeutic options for the management of neurologic diseases
3. Evaluate the latest basic and clinical research findings for neurologic diseases and their application to clinical practice

Target Audience
This activity is designed for neurologists, neuroscientists, fellows, residents, advanced practice nurses, nurses, and other healthcare providers involved in the management of patients with neurologic disorders.

Accreditation

In support of improving patient care, Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Declarations
Michael Schwarzschild, MD, PhD has the following relevant financial relationship with ineligible companies: Clinical Trial Steering Committee (via Parkinson Study Group Services): Biogen, UCB. All of the relevant financial relationships listed have been mitigated.

Speakers are required to disclose discussion of off-label/investigational uses of commercial products/devices in their presentation. These disclosures will be made to the audience at the time of the activity.

Planning Committee: Ram Gowda, MD, Nancy Song, MD, Shan Chen, MD, and Michelle Moccio, APN have no relevant financial relationships with ineligible companies to disclose. Asha Cilly, APN has relevant financial relationships with ineligible companies: Consultant: Catalyst, SK Life Science. All of the relevant financial relationships listed have been mitigated.
Rutgers Health CE staff: Patrick Dwyer and Elizabeth Ward have no relevant financial relationships with ineligible companies to disclose.